GlycoSeLect
GlycoSeLect specializes in the development of technology to separate glycoproteins for biopharmaceutical product analysis & manufacture.
GlycoSeLect operates in biotechnology, life science, medical based in European Union (EU), Europe, Middle East, and Africa (EMEA), founded in 2013.
As a business in biotechnology, life science, medical, GlycoSeLect is listed here with the public details available about it.
The company is recorded as being based in European Union (EU), Europe, Middle East, and Africa (EMEA).
Directory data places it at the Seed stage.
Its team size is recorded as c_00001_00010 employees.
Public records show total funding of about $45K.
| Sector | Biotechnology, Life Science, Medical |
|---|---|
| Headquarters | European Union (EU), Europe, Middle East, and Africa (EMEA) |
| Founded | 2013 |
| Employees | c_00001_00010 |
| Stage | seed |
| Total funding | $450,000 |
Website: www.glycoselect.com
Emails and contact routes are reserved for registered members.
Create a free account
Create a free account